Ibio Inc  

(Public, NYSEMKT:IBIO)   Watch this stock  
Find more results for NYSEAMEX:IBIO
0.900
-0.053 (-5.54%)
May 26 - Close
NYSEMKT real-time data - Disclaimer
Currency in USD
Range 0.90 - 0.98
52 week 0.24 - 3.48
Open 0.95
Vol / Avg. 0.00/1.92M
Mkt cap 69.82M
P/E     -
Div/yield     -
EPS -0.08
Shares 76.76M
Beta 1.51
Inst. own 4%

Key stats and ratios

Q1 (Mar '15) 2014
Net profit margin -480.52% -1788.29%
Operating margin -483.67% -1873.17%
EBITD margin - -1697.07%
Return on average assets -59.82% -46.26%
Return on average equity -68.08% -65.66%
Employees 7 -
CDP Score - -

Address

Suite 100, 9 Innovation Way, NEW CASTLE
NEWARK, DE 19711
United States - Map
+1-302-3550650 (Phone)
+1-302-3561173 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

iBio, Inc. (iBio) is a biotechnology company focused on commercializing its platform technologies. The Company’s platform technologies are iBioLaunch, for vaccines and therapeutic proteins and iBioModulator, for vaccine enhancement. The Company, through its platforms, derives and develops select product candidates. Vaccine candidates on its platform are applicable to newly emerging strains of hemagglutinin type 1 and neuraminidase type 1 (H1N1), swine-like influenza, hemagglutinin type 5 and neuraminidase type 1 (H5N1) avian influenza, yellow fever, and anthrax.

Officers and directors

Robert B. Kay Executive Chairman of the Board, Chief Executive Officer
Age: 73
Bio & Compensation  - Reuters
Robert L. Erwin President
Age: 59
Bio & Compensation  - Reuters
Mark Giannone Chief Financial Officer
Age: 57
Bio & Compensation  - Reuters
Terence Ryan Ph.D. Chief Scientific Officer
Age: 58
Bio & Compensation  - Reuters
Seymour Flug Director
Age: 78
Bio & Compensation  - Reuters
Glenn J. Chang CPA Independent Director
Age: 65
Bio & Compensation  - Reuters
Arthur Y. Elliott Ph.D. Independent Director
Age: 77
Bio & Compensation  - Reuters
James T. Hill Independent Director
Age: 67
Bio & Compensation  - Reuters
John D. McKey Jr. Independent Director
Age: 70
Bio & Compensation  - Reuters